The Keck School has the world renowned Alzheimer's Therapeutic Research Institute (ATRI) among it's many research centers and institutes. Taking a focus on clinical trials of innovative treatments to slow or prevent the disease’s progression – we are at the forefront of novel new treatments.
Building on the years of work in the Alzheimer's Disease Neuroimaging Initiative (ADNI) to optimizing infrastructure and shared expertise in the Alzheimer's Clinical Trials Consortium (ACTC) we are accelerating the path to a world without Alzheimer's.
Learn more about all the ways we are approaching Alzheimer's research at the Keck School of Medicine of USC.